USE OF PAN FGFR INHIBITORS AND METHOD OF IDENTIFYING PATIENTS WITH CANCER ELIGIBLE FOR TREATMENT WITH A PAN FGFR INHIBITOR.

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

Peter ELLINGHAUS,Melanie HEROULT

申请号：

MX2017007656

公开号：

MX2017007656A

申请日:

2015.12.08

申请国别(地区):

MX

年份:

2017

代理人:

摘要：

The current invention is based on a pan FGFR inhibitor for use in the treatment of cancer in a subject, wherein the subject is one for whom the sum of FGFR1, FGFR2 and/ or FGFR3 mRNA in a tumor tissue sample from the subject has been found to be overexpressed.La presente invención se basa en un inhibidor de pan FGFR para usar en el tratamiento del cáncer en un sujeto, donde el sujeto es aquel para quien se ha encontrado que la suma de ARNm de FGFR1, FGFR2 y/o FGFR3 en una muestra de tejido tumoral del sujeto está sobre-expresada.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/